Event

Brands, Generics and Hatch-Waxman: New Challenges; Unabated Controversy

Hosts

On Friday, June 24, 2011, Terry Mahn (DC) is speaking at the Food & Drug Law Institute’s “Brands, Generics and Hatch-Waxman: New Challenges; Unabated Controversy” conference at the Westin City Center in Washington, DC.

3:15-5:00 p.m.
Regulatory Strategies and Conundrums

  • Reference Drugs (withdrawals and changes)
  • 505 (b)(2) Issues
    • Selection of Reference Drug
    • Certifications
    • Exclusivity
  • Biosimilar Transitions Provisions

For more information or to register, click here.